Ticagrelor versus Prasugrel in Patients Undergoing Invasive Management of Coronary Artery Disease

31 August 2026 (14:30 - 14:45)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Daniele Giacoppo

AOU Policlinico - G. Rodolico San Marco, Catania (Italy)

3 More presentations in this session

Presentation thumbnail

Two-Year Outcomes of Intravascular Ultrasound Guided versus Angiography Guided Complex High-Risk Indicated Percutaneous Coronary Intervention

Doctor R. Diletti (Rotterdam, NL)

Presentation thumbnail

Long-term clinical outcomes in patients with angina and non obstructive coronary artery disease undergoing comprehensive invasive coronary function testing

Doctor P. Damman (Nijmegen, NL)

Presentation thumbnail

Twenty-Year Outcomes of a Randomized Comparison between Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis

Professor S. Desch (Leipzig, DE)

Access the full session

Session thumbnail

Better decisions in coronary revascularisation

The Event

Event poster

ESC Congress 2026

31 August 2026 14:30 CET

You may be interested in

Congress Presentation

Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials

31 August 2024

Congress Presentation

Incidence and pattern of repeat coronary revascularizations in patients with acute coronary syndromes treated with ticagrelor or prasugrel

27 August 2023

Congress Presentation

TADCLOT- Twice A Day CLOpidogrel vs. Ticagrelor post STEMI

30 August 2025

Congress Presentation

Is there a role for prasugrel monotherapy?

29 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources